San FranciscoAnd the September 20 2022 /PRNewswire/- CurbisToday, a company committed to democratizing access to clinical studies announced its partnership with Meru Health in a three-year clinical trial to determine the effectiveness of a 12-week online mental health care provider treatment program for reducing depression among primary care patients.
Meru Health is an app-based treatment program for depression, burnout, and anxiety with the guidance of a therapist. The program under study is a 12-week smartphone-based solution that goes beyond traditional standards of care, including talk therapy and medication.
The study, funded by the National Institutes of Health’s Small Business Innovation Research (SBIR) program, will be divided into two phases. In the proof-of-concept phase, 15 patients will undergo the Meru Health treatment program, while 15 patients will receive treatment as usual (such as face-to-face therapy, antidepressants or some combination) under the supervision of a primary care physician. .
Meru Health and Curebase will begin hiring for this first phase in early fall 2022 and is expected to finish in spring 2023. Curebase will be responsible for clinical site selection, patient recruitment, and data collection.
Curebase’s Decentralized Clinical Trials (DCT) platform allows clinical sites to streamline patient recruitment and approval processes before a clinical study begins. Once in a trial, the Curebase platform improves patient data capture, whether generated from a patient site visit or remotely through a telemedicine session.
Curebase allows patients to participate in Meru Health research in the context of their primary health care. For example, during an annual physical examination, a physician may assess a patient’s mental health, and if symptoms are indicative of someone with depression or general life anxiety, the physician may then refer a patient they identify as eligible for this study to this program. . If the patient passes the clinical examination and inclusion process, they will be directed to download the application and continue with the registration.
After analyzing the results and processes generated during the proof-of-concept study, Curebase and Meru Health will collaborate on a randomized controlled trial (RCT) that will include 300 participants and eight primary care clinics across the United States.
During the RCT phase, Curebase and Meru Health will collect and analyze ePROs or patient-reported electronic results. After participants complete treatment, researchers will track their progress for up to a year to determine if there are sustainable benefits for patients from Meru Health when compared to standard treatment as usual.
“Mercu Health’s smartphone-based mental health software shows tremendous potential to deliver effective and accessible treatment to a growing number of depression and anxiety patients,” said Curebase, CEO and founder. Tom Limberg. “We are excited to work with Meru Health on clinical research that can benefit millions of Americans.”
In addition to physician-on-call support, behavioral awareness, and biofeedback practices, Meru Health integrates sleep, nutrition, and social support into its treatment setting. This new app includes built-in functionality for collecting biofeedback data such as heart rate change through a device attached to the participant’s earlobe.
“A lot of people with mental health issues also struggle to get effective treatment and our solution was created to help these people,” he said. Christian Ranta, founder and CEO of Meru Health. “Curebase is an ideal partner for us because the company’s DCT platform and support services allow us to focus on the clinical aspects of these trials, while treating participating patients in a variety of locations.”
Approximately one in five Adults in the United States have mental illness and only half of Americans with mental health problems receive treatment, according to the National Institute of Mental Health. severely 280 billion dollars I was spend on mental health services in 2020.
Our mission at Curebase is to deliver high-quality medical innovations to patients faster and improve human well-being through more efficient clinical studies. We are demonstrating that clinical research can be radically accelerated if we empower physicians everywhere to enroll patients in the communities in which they live. By applying the latest clinical software and remote study management techniques to solve the problem, we are reinventing clinical trials and research from the ground up. For more information, please visit the website www.curebase.com.
About Meru . Health
Meru Health is setting a new standard in mental healthcare with the most comprehensive online solution that combines licensed therapists and psychiatrists, a smartphone-based therapy program, biofeedback training, anonymous peer support, habits-changing activities for sleep and nutrition and more. The company is committed to evidence-based care and has published groundbreaking clinical results with stanfordAnd the Harvardand UC Davis that demonstrates promising clinical efficacy and lasting results provides a convenient, accessible, and side-effect-free option for mental health treatment unlike the standard of care in the United States today. Meru Health partners with major health insurance providers such as Cigna, Humana and Moda Health, as well as leading companies that want to provide the best mental health care to their employees or members. For more information visit www.meruhealth.com and follow us LinkedInAnd the FacebookAnd the Twitter.
Amendola Communications (for Curebase)